Company profile for AiViva Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AiViva BioPharma is a clinical-stage biotech company led by a team of seasoned industry experts with a proven track record in the development of commercial drug products. AiViva has developed novel technologies to address unmet medical needs by transforming existing treatments to create localized, targeted treatment of diseases while lowering systemic exposure. Our core competency includes development of drugs using our prop...
AiViva BioPharma is a clinical-stage biotech company led by a team of seasoned industry experts with a proven track record in the development of commercial drug products. AiViva has developed novel technologies to address unmet medical needs by transforming existing treatments to create localized, targeted treatment of diseases while lowering systemic exposure. Our core competency includes development of drugs using our proprietary JEL™ Technology in specialty therapeutic areas of Dermatology, Ophthalmology, Urology, and Oncology.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1300 Bristol St N, Suite 220, Newport Beach, California 92660
Telephone
Telephone
(949) 662-1949
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/12/09/2993633/0/en/AiViva-Biopharma-Receives-FDA-Clearance-to-Administer-AIV001-in-Facial-Skin-by-Intradermal-Injection-for-Nonmelanoma-Skin-Cancer.html

GLOBENEWSWIRE
09 Dec 2024

https://www.pharmabiz.com/NewsDetails.aspx?aid=172106&sid=2

PHARMABIZ
26 Aug 2024

https://www.globenewswire.com/news-release/2024/08/23/2934831/0/en/AiViva-Biopharma-Completes-Enrollment-in-a-Phase-1-Clinical-Trial-of-AIV007-for-Age-Related-Macular-Degeneration-and-Diabetic-Macular-Edema.html

GLOBENEWSWIRE
23 Aug 2024

https://www.globenewswire.com//news-release/2023/12/11/2793822/0/en/AiViva-Biopharma-Completes-Phase-1-2-Clinical-Trial-of-AIV001-Administration-in-Patients-with-Nonmelanoma-Skin-Cancer.html

GLOBENEWSWIRE
11 Dec 2023

https://www.globenewswire.com//news-release/2023/09/18/2744532/0/en/AiViva-Biopharma-Appoints-Lester-J-Kaplan-PhD-to-the-Board-of-Directors.html

GLOBENEWSWIRE
18 Sep 2023

https://www.globenewswire.com//news-release/2023/08/29/2733955/0/en/AiViva-Biopharma-Appoints-Jung-Chin-Rongjin-Lin-to-the-Board-of-Directors.html

GLOBENEWSWIRE
29 Aug 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty